Literature DB >> 4014441

Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

H Ratech, M A Greco, G Gallo, D L Rimoin, H Kamino, R Hirschhorn.   

Abstract

The authors have reviewed the autopsies of 8 patients with adenosine-deaminase-deficient severe combined immunodeficiency disease (ADA-SCID). Several new findings in nonlymphoid organs, including kidney and adrenal gland, and chondro-osseous tissue indicate the multisystem nature of this disorder. Examination of renal tissue in 7 of 8 cases showed mesangial sclerosis. This was confirmed in 3 cases by electron microscopy. One case, treated with multiple erythrocyte partial exchange transfusions for several years, had no mesangial sclerosis. Six of 8 cases showed adrenal-gland cortical sclerosis. Chondro-osseous tissue from vertebrae and costochondral junctions of 4 cases examined showed typical alterations previously reported in ADA-SCID such as short growth plates with few proliferating and some hypertrophic chondrocytes. The authors report the new observations of necrotic chondrocytes, as well as large amounts of cellular debris. These changes were not observed in the 2 other patients examined, who received bone marrow or multiple partial exchange transfusions. The distribution and severity of these lesions, their relationship to ADA replacement therapy, and their homology to mice treated with a potent ADA inhibitor suggests that, in addition to lymphoid dysfunction, disordered nucleoside metabolism due to absent ADA activity in ADA-SCID may be the cause of diverse multi-system pathologic changes in tissues which continue to differentiate or mature after birth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4014441      PMCID: PMC1887960     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Congenital nephrotic syndrome of Finnish type. Study of 75 patients.

Authors:  N P Huttunen
Journal:  Arch Dis Child       Date:  1976-05       Impact factor: 3.791

2.  Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency. Albany, New York, on October 1, 1973.

Authors:  R J Pickering; B Pollara; H J Meuwissen
Journal:  Clin Immunol Immunopathol       Date:  1974-11

3.  Adenosine deaminase deficiency in a child with severe combined immunodeficiency.

Authors:  B B Knudsen; J Dissing
Journal:  Clin Genet       Date:  1973       Impact factor: 4.438

4.  Adenosine-deaminase deficiency and combined immunodeficiency syndrome.

Authors:  J Dissing; B Knudsen
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

5.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

6.  Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency.

Authors:  J Yount; P Nichols; H D Ochs; S P Hammar; C R Scott; S H Chen; E R Giblett; R J Wedgwood
Journal:  J Pediatr       Date:  1974-02       Impact factor: 4.406

7.  Severe combined immunodeficiency and adenosine deaminase deficiency.

Authors:  R Parkman; E W Gelfand; F S Rosen; A Sanderson; R Hirschhorn
Journal:  N Engl J Med       Date:  1975-04-03       Impact factor: 91.245

8.  Antibodies to nucleic acids in congenital immune deficiency states.

Authors:  M E Gershwin; R M Blaese; A D Steinberg; R Wistar; W Strober
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

Review 9.  Infantile nephrotic syndrome.

Authors:  C R George; R O Hickman; G E Stricker
Journal:  Clin Nephrol       Date:  1976-01       Impact factor: 0.975

10.  [Heterogeneity of early onset nephrotic syndromes in infants (nephrotic syndrome "in infants"). Anatomical, clinical and genetic study of 37 cases].

Authors:  R Habib; E Bois
Journal:  Helv Paediatr Acta       Date:  1973-05
View more
  23 in total

1.  A2B adenosine receptor-mediated induction of IL-6 promotes CKD.

Authors:  Yingbo Dai; Weiru Zhang; Jiaming Wen; Yujin Zhang; Rodney E Kellems; Yang Xia
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.

Authors:  Olga Nikolajeva; Austen Worth; Rosie Hague; Nuria Martinez-Alier; Joanne Smart; Stuart Adams; E Graham Davies; H Bobby Gaspar
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

Review 3.  Acquired chondronecrosis.

Authors:  L Sokoloff
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

4.  Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.

Authors:  Robert Sokolic; Irina Maric; Chimene Kesserwan; Elizabeth Garabedian; I Celine Hanson; Margaret Dodds; Rebecca Buckley; Andrew C Issekutz; Naynesh Kamani; Kit Shaw; Ben Tan; Pawan Bali; Michael S Hershfield; Donald B Kohn; Alan S Wayne; Fabio Candotti
Journal:  Blood       Date:  2011-07-01       Impact factor: 22.113

5.  Chest Radiographs for Distinguishing ADA-SCID from Other Forms of SCID.

Authors:  Martijn V Verhagen; Valentina Trevisan; John Adu; Catherine M Owens; Claire Booth; Alistair Calder
Journal:  J Clin Immunol       Date:  2019-12-19       Impact factor: 8.317

Review 6.  Adenosine and bone metabolism.

Authors:  Aránzazu Mediero; Bruce N Cronstein
Journal:  Trends Endocrinol Metab       Date:  2013-03-14       Impact factor: 12.015

7.  Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.

Authors:  A Shanon; S Levin; F Holtzman; F Brock-Sinai; A Abu-Said
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

8.  Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.

Authors:  L D Notarangelo; G Stoppoloni; R Toraldo; E Mazzolari; A Coletta; P Airò; C Bordignon; A G Ugazio
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

9.  Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice.

Authors:  M Wakamiya; M R Blackburn; R Jurecic; M J McArthur; R S Geske; J Cartwright; K Mitani; S Vaishnav; J W Belmont; R E Kellems
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID).

Authors:  Claire Booth; H Bobby Gaspar
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.